Category Archives: BioUtah News
Halia Therapeutics to Participate in Panel at BIO Investor Forum 2024
LEHI, Utah, Oct. 14, 2024 /PRNewswire/ — Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company at the forefront of developing innovative treatments for inflammatory and neurodegenerative diseases, today announced that David J. Bearss, Ph.D., President and CEO of Halia Therapeutics, will participate in a panel at the BIO Investor Forum taking place October 15-16, 2024, in […]
Canary Speech Launches Canary Ambient™, a First-of-its-Kind, Real-Time Voice Analysis for Clinical Conversations
Canary Ambient™ enables actionable insights into patient-clinician dialogues, tracking speech patterns, and delivering real-time evaluations of cognitive and behavioral health conditions PROVO, Utah, Oct. 16, 2024 /PRNewswire/ — Canary Speech, a leader in vocal biomarker technology, has announced today the launch of Canary Ambient™, an API-first solution designed for healthcare and contact centers, which offers a […]
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access
SALT LAKE CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) — Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a strategic partnership with jscreen™, a national organization that delivers education and access to preventative genetic testing with a focus on high-risk populations. The collaboration combines the strengths of Myriad’s high-quality […]
Canyon Labs Expands Capabilities With Acquisition of Life Pack Labs
Utah-based Canyon Labs announces its strategic acquisition of Life Pack Labs in California, broadening its service offerings and enhancing its position as an industry leader in medical device and pharmaceutical compliance testing. SALT LAKE CITY, October 8, 2024 (Newswire.com) – Canyon Labs, a leading medical device & pharmaceutical consulting, sterility assurance, analytical chemistry and package […]
Scientists at Utah State University Receive Grants to Study Two Important Viruses
Researchers at Utah State University, led by Professor Zhongde Wang and collaborating with teams at University of Texas Medical Branch and University of Pittsburgh, respectively, have secured two grants from the National Institutes of Health (NIH) totaling more than $4 million in recent months to advance the understanding of two important global health threats. In […]
Life Sciences Delegation Participates in Governor’s Trade Mission to Korea and Japan
BioUtah and five BioUtah member companies participated in the Governor’s trade mission to Korea and Japan organized by World Trade Center Utah. Led by BioUtah president and CEO, Kelvyn Cullimore, the life sciences delegation included Dwight Egan, Seth Egan and Richard Abbott of CoDiagnostics, Mike Kirkness and Lucas Bennink of 3Helix, Taylor Avei of Halia […]
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan
SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah Governor Cox and the Governor’s Office of Economic Opportunity, as part of the latest World Trade Center (WTC) Utah trade […]
BioUtah Member BBQ Recap
BioUtah’s annual membership appreciation BBQ was held yesterday at the Gateway’s Hidden Gem Patio. The event was a great way for the nearly 200 registrants to network with colleagues and make new connections. Prior to the BBQ, an executive reception was held, with several BioUtah Board members present. Also, in conjunction with the BBQ, the […]
BD Completes Acquisition of Critical Care from Edwards Lifesciences
BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring.
Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe
Owlet debuts new Dream Sock at Kind + Jugend 2024 and shares that the device will soon be available to even more parents across the globe.
Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability
REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies.
FIRST ALL-FEMALE TAVI TRIAL SHOWS EXCELLENT OUTCOMES FOR WOMEN RECEIVING EDWARDS VALVES
Edwards Lifesciences announced the results from the RHEIA Trial.
